Back to Search
JUDITH ROSENSTOCK, PH.D.
PH.D.
Psychologist
NPI: 1154477347Individual
Specialties, Licenses & Credentials
PsychologistPrimary
Psychologist
Code: 103T00000X
PSY5990(CA)
Research & Publications (20)
Long-term 2-year safety and efficacy of vildagliptin compared with rosiglitazone in drug-naïve patients with type 2 diabetes mellitus.
PMID 19383032·Diabetes Obes Metab·2009
4-observational
Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing.
PMID 19592625·Diabetes Care·2009
2-rct
Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes.
PMID 19650754·Curr Med Res Opin·2009
2-rct
Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study.
PMID 19526210·Diabetologia·2009
4-observational
Vildagliptin: clinical trials programme in monotherapy and combination therapy for type 2 diabetes.
PMID 18269437·Int J Clin Pract Suppl·2008
6-review
Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes.
PMID 18355324·Diabetes Obes Metab·2008
4-observational
Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy.
PMID 17934150·Diabetes Care·2008
2-rct
Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agents.
PMID 18678610·Diabetes Care·2008
4-observational
Potential benefits of early addition of rosiglitazone in combination with glimepiride in the treatment of type 2 diabetes.
PMID 18201206·Diabetes Obes Metab·2008
2-rct
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes.
PMID 18204830·Diabetologia·2008
4-observational
Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial.
PMID 17259484·Diabetes Care·2007
2-rct
Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus.
PMID 17940427·Curr Opin Endocrinol Diabetes Obes·2007
6-review
AIR Inhaled Insulin System: a novel insulin-delivery system for patients with diabetes.
PMID 17850203·Expert Rev Med Devices·2007
6-review
Reflecting on type 2 diabetes prevention: more questions than answers!
PMID 17877541·Diabetes Obes Metab·2007
6-review
Comparison of standard (self-directed) versus intensive patient training for the human insulin inhalation powder (HIIP) delivery system in patients with type 2 diabetes: efficacy, safety, and training measures.
PMID 17316102·Diabetes Technol Ther·2007
3-trial
Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.
PMID 16505505·Diabetes Care·2006
4-observational
Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.
PMID 16230721·Ann Intern Med·2005
3-trial
Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.
PMID 15793205·Diabetes Care·2005
4-observational
Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial.
PMID 15288403·Pain·2004
3-trial
Beyond a beautiful mind: film choices for teaching schizophrenia.
PMID 12824113·Acad Psychiatry·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 566 S SAN VICENTE BLVD, #101
LOS ANGELES, CA 90048 - Phone
- (323) 653-5279
Quick Facts
- NPI
- 1154477347
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile